S. Yener Et Al. , "Soluble CD40 Ligand, Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fibrinolysis Inhibitor-1-Antigen in Normotensive Type 2 Diabetic Subjects without Diabetic Complications," MEDICAL PRINCIPLES AND PRACTICE , vol.18, no.4, pp.266-271, 2009
Yener, S. Et Al. 2009. Soluble CD40 Ligand, Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fibrinolysis Inhibitor-1-Antigen in Normotensive Type 2 Diabetic Subjects without Diabetic Complications. MEDICAL PRINCIPLES AND PRACTICE , vol.18, no.4 , 266-271.
Yener, S., ÇÖMLEKÇİ, A., AKINCI, B., DEMİR, T., YÜKSEL, F., ÖZCAN, M. A., ... BAYRAKTAR, F.(2009). Soluble CD40 Ligand, Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fibrinolysis Inhibitor-1-Antigen in Normotensive Type 2 Diabetic Subjects without Diabetic Complications. MEDICAL PRINCIPLES AND PRACTICE , vol.18, no.4, 266-271.
Yener, Serkan Et Al. "Soluble CD40 Ligand, Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fibrinolysis Inhibitor-1-Antigen in Normotensive Type 2 Diabetic Subjects without Diabetic Complications," MEDICAL PRINCIPLES AND PRACTICE , vol.18, no.4, 266-271, 2009
Yener, Serkan Et Al. "Soluble CD40 Ligand, Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fibrinolysis Inhibitor-1-Antigen in Normotensive Type 2 Diabetic Subjects without Diabetic Complications." MEDICAL PRINCIPLES AND PRACTICE , vol.18, no.4, pp.266-271, 2009
Yener, S. Et Al. (2009) . "Soluble CD40 Ligand, Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fibrinolysis Inhibitor-1-Antigen in Normotensive Type 2 Diabetic Subjects without Diabetic Complications." MEDICAL PRINCIPLES AND PRACTICE , vol.18, no.4, pp.266-271.
@article{article, author={Serkan Yener Et Al. }, title={Soluble CD40 Ligand, Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fibrinolysis Inhibitor-1-Antigen in Normotensive Type 2 Diabetic Subjects without Diabetic Complications}, journal={MEDICAL PRINCIPLES AND PRACTICE}, year=2009, pages={266-271} }